RACHEL PRYTULA: Open Payments
NPI 1861827941 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,870 in 139 payments from 44 companies in 2025. Trend: 2023 $2,902 · 2024 $3,034 · 2025 $2,870
Food & beverage: $2,870
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $235 |
| Novartis Pharmaceuticals Corporation | 9 | $197 |
| Incyte Corporation | 10 | $196 |
| AstraZeneca Pharmaceuticals LP | 10 | $174 |
| BeOne Medicines USA, Inc. | 3 | $165 |
| ABBVIE INC. | 7 | $157 |
| Merck Sharp & Dohme LLC | 7 | $153 |
| Janssen Biotech, Inc. | 8 | $139 |
| Genentech USA, Inc. | 6 | $113 |
| Daiichi Sankyo Inc. | 5 | $113 |
Products named: OPDIVO, BRUKINSA, KEYTRUDA, Enhertu, JAKAFI, MONJUVI, LIBTAYO, VENCLEXTA.
Industry payments across AL — which companies pay providers there.
